review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Charles Aidemise Oyinbo | |
P433 | issue | 2 | |
P304 | page(s) | 281-299 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | Acta Neurobiologiae Experimentalis | Q15753705 |
P1476 | title | Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade | |
P478 | volume | 71 |
Q52720025 | A Single Dose of Atorvastatin Applied Acutely after Spinal Cord Injury Suppresses Inflammation, Apoptosis, and Promotes Axon Outgrowth, Which Might Be Essential for Favorable Functional Outcome. |
Q35571359 | A disintegrin and metalloprotease 17 promotes microglial cell survival via epidermal growth factor receptor signalling following spinal cord injury |
Q93173157 | A novel CX3CR1 inhibitor AZD8797 facilitates early recovery of rat acute spinal cord injury by inhibiting inflammation and apoptosis |
Q92541111 | A transcriptomic study of probenecid on injured spinal cords in mice |
Q37424039 | ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in mice. |
Q60949826 | Activation of the Large-Conductance, Voltage, and Ca- Activated K (BK) Channel in Acute Spinal Cord Injury in the Wistar Rat Is Neuroprotective |
Q35255695 | Acute administration of AMPA/Kainate blocker combined with delayed transplantation of neural precursors improves lower urinary tract function in spinal injured rats |
Q38927552 | Aldose Reductase Regulates Microglia/Macrophages Polarization Through the cAMP Response Element-Binding Protein After Spinal Cord Injury in Mice |
Q54940839 | Amiloride Promotes Oligodendrocyte Survival and Remyelination after Spinal Cord Injury in Rats. |
Q38057671 | An update on spinal cord injury research |
Q30360306 | Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents. |
Q30838780 | Analyzing time-series microarray data reveals key genes in spinal cord injury |
Q52577506 | Annexins in Glaucoma. |
Q37286209 | Anti-Inflammatory Mechanism of Neural Stem Cell Transplantation in Spinal Cord Injury |
Q36130272 | Antibody profiling identifies novel antigenic targets in spinal cord injury patients. |
Q38782411 | Antibody-mediated inhibition of Nogo-A signaling promotes neurite growth in PC-12 cells |
Q36321592 | Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury |
Q55280839 | Apolipoprotein E Deficiency Exacerbates Spinal Cord Injury in Mice: Inflammatory Response and Oxidative Stress Mediated by NF-κB Signaling Pathway. |
Q64088535 | Application of Hepatocyte Growth Factor for Acute Spinal Cord Injury: The Road from Basic Studies to Human Treatment |
Q64915564 | BET protein inhibition regulates cytokine production and promotes neuroprotection after spinal cord injury. |
Q47226900 | Biomarkers in Spinal Cord Injury: from Prognosis to Treatment |
Q26780494 | Biomaterial Approaches to Enhancing Neurorestoration after Spinal Cord Injury: Strategies for Overcoming Inherent Biological Obstacles |
Q47332307 | Biomaterial strategies for limiting the impact of secondary events following spinal cord injury. |
Q33653678 | Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord. |
Q51295310 | Blood metabolic response to a long-term wheelchair rugby training. |
Q90305344 | CCL28 promotes locomotor recovery after spinal cord injury via recruiting regulatory T cells |
Q35372296 | CSF proteomics of secondary phase spinal cord injury in human subjects: perturbed molecular pathways post injury |
Q39261219 | Cell transplantation therapy for spinal cord injury. |
Q42823772 | Chrysin suppressed inflammatory responses and the inducible nitric oxide synthase pathway after spinal cord injury in rats |
Q94452060 | Clinical Outcomes of Intraoperative Contrast-Enhanced Ultrasound Compared with Intraoperative Neurophysiological Monitoring During Circumferential Decompression for Myelopathy Associated with Thoracic-Ossification of the Posterior Longitudinal Ligam |
Q26752052 | Clinical proteomics of enervated neurons |
Q89287500 | Coenzyme Q10 Influences on the Levels of TNF-α and IL-10 and the Ratio of Bax/Bcl2 in a Menopausal Rat Model Following Lumbar Spinal Cord Injury |
Q64972687 | Combined Rosiglitazone and Forskolin Have Neuroprotective Effects in SD Rats after Spinal Cord Injury. |
Q31011460 | Comparative analysis of molecular mechanism of spinal cord injury with time based on bioinformatics data |
Q57031032 | Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats |
Q26740237 | Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord Injury |
Q36463599 | Degeneration of phrenic motor neurons induces long-term diaphragm deficits following mid-cervical spinal contusion in mice |
Q47168933 | Design and criteria of electrospun fibrous scaffolds for the treatment of spinal cord injury |
Q37356682 | Different TLR4 expression and microglia/macrophage activation induced by hemorrhage in the rat spinal cord after compressive injury |
Q34541548 | Direct optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivo |
Q92326230 | Dual-Functioning Scaffolds for the Treatment of Spinal Cord Injury: Alginate Nanofibers Loaded with the Sigma 1 Receptor (S1R) Agonist RC-33 in Chitosan Films |
Q64076339 | Dynamic changes in intramedullary pressure 72 hours after spinal cord injury |
Q55384158 | Early electrical field stimulation prevents the loss of spinal cord anterior horn motoneurons and muscle atrophy following spinal cord injury. |
Q30235313 | Early versus late spinal decompression surgery in treatment of traumatic spinal cord injuries; a systematic review and meta-analysis |
Q55090119 | Ecto-5'-nucleotidase (CD73) attenuates inflammation after spinal cord injury by promoting macrophages/microglia M2 polarization in mice. |
Q38602852 | Effect of chondroitinase ABC on inflammatory and oxidative response following spinal cord injury |
Q53078216 | Effect of electrical stimulation on neural regeneration via the p38-RhoA and ERK1/2-Bcl-2 pathways in spinal cord-injured rats. |
Q30834225 | Effect of hierarchically aligned fibrin hydrogel in regeneration of spinal cord injury demonstrated by tractography: A pilot study |
Q33586613 | Effect of hypovolemia on traumatic spinal cord injury |
Q35632010 | Effect of pollen typhae on inhibiting autophagy in spinal cord injury of rats and its mechanisms |
Q36645115 | Effects of a voltage sensitive calcium channel blocker and a sodium-calcium exchanger inhibitor on apoptosis of motor neurons in adult spinal cord slices |
Q39324758 | Electrospun Fibers for Drug Delivery after Spinal Cord Injury and the Effects of Drug Incorporation on Fiber Properties |
Q64243004 | Elevated Serum Melatonin under Constant Darkness Enhances Neural Repair in Spinal Cord Injury through Regulation of Circadian Clock Proteins Expression |
Q54092817 | Endoplasmic reticulum stress transducer old astrocyte specifically induced substance contributes to astrogliosis after spinal cord injury. |
Q55394119 | Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury. |
Q36204566 | Epimedium koreanum Extract and Its Constituent Icariin Improve Motor Dysfunction in Spinal Cord Injury |
Q35610320 | Evaluation of poly(3,4-ethylenedioxythiophene)/carbon nanotube neural electrode coatings for stimulation in the dorsal root ganglion. |
Q52583995 | Exosomes in Acquired Neurological Disorders: New Insights into Pathophysiology and Treatment. |
Q34325082 | Expression of suppressor of cytokine signaling-3 (SOCS3) and its role in neuronal death after complete spinal cord injury |
Q27024453 | Function of microglia and macrophages in secondary damage after spinal cord injury |
Q37647554 | Genetic and Pharmacological Inhibition of p38α Improves Locomotor Recovery after Spinal Cord Injury |
Q58702687 | Glial fibrillary acidic protein levels are associated with global histone H4 acetylation after spinal cord injury in rats |
Q47566621 | Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury |
Q33634585 | HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injury |
Q36590647 | Hindlimb muscle morphology and function in a new atrophy model combining spinal cord injury and cast immobilization |
Q41906811 | Hormonal therapy in traumatic spinal cord injury |
Q36668099 | Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. |
Q37474587 | IKVAV-linked cell membrane-spanning peptide treatment induces neuronal reactivation following spinal cord injury. |
Q46387484 | Immunobiology of spinal cord injuries and potential therapeutic approaches |
Q48736346 | Impact of Heat Shock Protein A 12B Overexpression on Spinal Astrocyte Survival Against Oxygen-Glucose-Serum Deprivation/Restoration in Primary Cultured Astrocytes. |
Q36307448 | Implantable porous gelatin microspheres sustained release of bFGF and improved its neuroprotective effect on rats after spinal cord injury |
Q42100195 | In Vivo Monitoring of Rat Spinal Cord Metabolism Using Hyperpolarized Carbon-13 MR Spectroscopic Imaging |
Q36195243 | In vivo effects of L1 coating on inflammation and neuronal health at the electrode-tissue interface in rat spinal cord and dorsal root ganglion |
Q38741473 | Increased expression of ApoA1 after neuronal injury may be beneficial for healing |
Q89453754 | Inflammation and blood-brain barrier breach remote from the primary injury following neurotrauma |
Q48197077 | Insights into the Dual Role of Inflammation after Spinal Cord Injury |
Q47952559 | Interactions of primary insult biomechanics and secondary cascades in spinal cord injury: implications for therapy |
Q36756735 | Intraspinal Delivery of Polyethylene Glycol-coated Gold Nanoparticles Promotes Functional Recovery After Spinal Cord Injury. |
Q57454960 | Lithium promotes recovery of neurological function after spinal cord injury by inducing autophagy |
Q48038011 | Local delivery of minocycline from metal ion-assisted self-assembled complexes promotes neuroprotection and functional recovery after spinal cord injury |
Q92368930 | Long non-coding RNAs in the spinal cord injury: Novel spotlight |
Q33673593 | Low-level laser facilitates alternatively activated macrophage/microglia polarization and promotes functional recovery after crush spinal cord injury in rats |
Q92564628 | Magnetic Composite Biomaterials for Neural Regeneration |
Q38248005 | Mechanisms of secondary degeneration after partial optic nerve transection |
Q41043799 | Mechanisms underlying the promotion of functional recovery by deferoxamine after spinal cord injury in rats |
Q52654285 | Melatonin treatment protects against acute spinal cord injury-induced disruption of blood spinal cord barrier in mice. |
Q98158954 | Mesenchymal Stem/Stromal Cell-Mediated Mitochondrial Transfer and the Therapeutic Potential in Treatment of Neurological Diseases |
Q38207597 | Mesenchymal stem cells in the treatment of spinal cord injuries: A review |
Q47222219 | Methylene Blue Mitigates Acute Neuroinflammation after Spinal Cord Injury through Inhibiting NLRP3 Inflammasome Activation in Microglia |
Q50948659 | MiR-25 protects PC-12 cells from H2O2 mediated oxidative damage via WNT/β-catenin pathway. |
Q37601818 | MicroRNA dysregulation in spinal cord injury: causes, consequences and therapeutics. |
Q35020885 | MicroRNAs as potential therapeutics for treating spinal cord injury |
Q39374470 | Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury. |
Q47163634 | Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target |
Q90630278 | Modulation of autophagy for neuroprotection and functional recovery in traumatic spinal cord injury |
Q54506417 | Monocyte locomotion inhibitory factor produced by E. histolytica improves motor recovery and develops neuroprotection after traumatic injury to the spinal cord. |
Q93047753 | Multimodal treatment for spinal cord injury: a sword of neuroregeneration upon neuromodulation |
Q39848771 | Multiparametric MRI reveals dynamic changes in molecular signatures of injured spinal cord in monkeys |
Q28066958 | Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship |
Q39415268 | Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury |
Q48595101 | Naringin treatment improves functional recovery by increasing BDNF and VEGF expression, inhibiting neuronal apoptosis after spinal cord injury |
Q93051215 | Necrosulfonamide Ameliorates Neurological Impairment in Spinal Cord Injury by Improving Antioxidative Capacity |
Q46484412 | Neural Stem Cell-Conditioned Medium Suppresses Inflammation and Promotes Spinal Cord Injury Recovery. |
Q90396268 | Neurological recovery and antioxidant effects of resveratrol in rats with spinal cord injury: a meta-analysis |
Q36892833 | Neuron specific enolase: a promising therapeutic target in acute spinal cord injury |
Q35804587 | Neuroprotective Effect of Ulinastatin on Spinal Cord Ischemia-Reperfusion Injury in Rabbits |
Q92066428 | Neuroprotective Effects of Combined Treatment with Minocycline and Olfactory Ensheathing Cells Transplantation against Inflammation and Oxidative Stress after Spinal Cord Injury |
Q86602127 | Neuroprotective effect of apigenin in rats after contusive spinal cord injury |
Q36095115 | Neuroprotective effect of methylprednisolone combined with placenta-derived mesenchymal stem cell in rabbit model of spinal cord injury |
Q36321781 | Neuroprotective effects of electroacupuncture on early- and late-stage spinal cord injury |
Q34240286 | Neutrophil contribution to spinal cord injury and repair |
Q90009266 | Noninvasive Quantification of Axonal Loss in the Presence of Tissue Swelling in Traumatic Spinal Cord Injury Mice |
Q27339920 | Optical monitoring and detection of spinal cord ischemia |
Q41371138 | Oral Administration of Red Ginseng Extract Promotes Neurorestoration after Compressive Spinal Cord Injury in Rats |
Q33671711 | Overexpression of the astrocyte glutamate transporter GLT1 exacerbates phrenic motor neuron degeneration, diaphragm compromise, and forelimb motor dysfunction following cervical contusion spinal cord injury. |
Q49440845 | Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells |
Q64101908 | Pectolinarigenin promotes functional recovery and inhibits apoptosis in rats following spinal cord injuries |
Q47739408 | Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair |
Q57038642 | Pharmacological stimulation of mitochondrial biogenesis using the FDA-approved β 2 -adrenoreceptor agonist formoterol for the treatment of spinal cord injury |
Q35983143 | Photothrombosis-induced Focal Ischemia as a Model of Spinal Cord Injury in Mice. |
Q42129572 | RETRACTED: Serotonin 5-HT7 receptor agonist, LP-211, exacerbates Na(+), K(+)-ATPase/Mg(2+)-ATPase imbalances in spinal cord-injured male rats. |
Q28535228 | RNA-seq characterization of spinal cord injury transcriptome in acute/subacute phases: a resource for understanding the pathology at the systems level |
Q98946060 | Reactive Astrogliosis: Implications in Spinal Cord Injury Progression and Therapy |
Q89584311 | Recent update on basic mechanisms of spinal cord injury |
Q94544496 | Regeneration Through in vivo Cell Fate Reprogramming for Neural Repair |
Q47399427 | Regulatory effect of neuroglobin in the recovery of spinal cord injury |
Q36875937 | Rescuing macrophage normal function in spinal cord injury with embryonic stem cell conditioned media |
Q50051397 | Retinal genes are differentially expressed in areas of primary versus secondary degeneration following partial optic nerve injury |
Q38481453 | Role of Wnt Signaling in Central Nervous System Injury |
Q38713865 | Role of hypoxia‑inducible factor‑1α in autophagic cell death in microglial cells induced by hypoxia |
Q36790871 | Salvianolic acid B protects the myelin sheath around injured spinal cord axons |
Q92737487 | Serum and Cerebrospinal Fluid Levels of S-100β Is A Biomarker for Spinal Cord Injury; a Systematic Review and Meta-Analysis |
Q36947678 | Spatial and temporal morphological changes in the subarachnoid space after graded spinal cord contusion in the rat. |
Q27026103 | Sphingolipids in spinal cord injury |
Q88538756 | Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses |
Q40099988 | Spontaneous acute and chronic spinal cord injuries in paraplegic dogs: a comparative study of in vivo diffusion tensor imaging |
Q46333626 | Spontaneous nervous system concussion in dogs: a description of two cases and a review of terminology in veterinary medicine. |
Q52619084 | Stem Cells Therapy for Spinal Cord Injury. |
Q37631387 | Stem Cells and Labeling for Spinal Cord Injury |
Q88801808 | Stem Cells from Human Exfoliated Deciduous Teeth Modulate Early Astrocyte Response after Spinal Cord Contusion |
Q36915826 | Stem cell therapy in spinal cord injury: Hollow promise or promising science? |
Q53825391 | Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury. |
Q36554957 | Temporal and Regional Expression of Glucose-Dependent Insulinotropic Peptide and Its Receptor in Spinal Cord Injured Rats |
Q55222910 | The Comprehensive Therapy of Electroacupuncture Promotes Regeneration of Nerve Fibers and Motor Function Recovery in Rats after Spinal Cord Injury. |
Q51303083 | The Expression of IGFBP6 after Spinal Cord Injury: Implications for Neuronal Apoptosis. |
Q42315725 | The SDF-1/CXCR4 axis promotes recovery after spinal cord injury by mediating bone marrow-derived from mesenchymal stem cells. |
Q36420219 | The change tendency of PI3K/Akt pathway after spinal cord injury |
Q99583681 | The combination of forskolin and VPA increases gene expression efficiency to the hypoxia/neuron-specific system |
Q58794847 | The combination of induced pluripotent stem cells and bioscaffolds holds promise for spinal cord regeneration |
Q91814524 | The effects of barnidipine on an experimental ischemia reperfusion model of spinal cord injury and comparison with methyl prednisolone |
Q57065486 | The endoplasmic reticulum stress transducer old astrocyte specifically induced substance positively regulates glial scar formation in spinal cord injury |
Q37018241 | The immunomodulator decoy receptor 3 improves locomotor functional recovery after spinal cord injury |
Q35180002 | The role of the JAK-STAT pathway in neural stem cells, neural progenitor cells and reactive astrocytes after spinal cord injury |
Q92017572 | The superiority of conditioned medium derived from rapidly expanded mesenchymal stem cells for neural repair |
Q89882550 | Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration |
Q90661201 | Transplantation of M2-Deviated Microglia Promotes Recovery of Motor Function after Spinal Cord Injury in Mice |
Q64061191 | Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms |
Q52676147 | Treatment with Interleukin-19 improves locomotor functional recovery after contusion spinal cord trauma. |
Q41453556 | Valproic acid reduces autophagy and promotes functional recovery after spinal cord injury in rats |
Q58580346 | Yellow Laser Stimulation at GV2 Acupoint Mitigates Apoptosis, Oxidative Stress, Inflammation, and Motor Deficit in Spinal Cord Injury Rats |
Q52675589 | [Efficacy of intramedullary and extramedullary decompression and lavage therapy under microscope for treatment of chronic cervical spinal cord injury]. |